发明名称 INTRADUCTAL MANAGEMENT OF BREAST LESIONS INVOLVING THERAPEUTIC OR DIAGNOSTIC AGENTS
摘要 <p>The present invention relates to an apparatus and method for administering a radioactive tracer dye and an inhibitor compound into a breast duct of the breast and imaging the breast for breast lesions. The radioactive tracer dye may be Tc-99m sestamibi and the inhibitor compound may inhibit a P-glycoprotein pump in tumor cells. When the inhibitor compound inhibits the P-glycoprotein pump in tumor cells, the radioactive tracer dye may effectively accumulate in tumor cells and improve the sensitivity of nuclear imaging of breast lesions.</p>
申请公布号 AU2003233391(A1) 申请公布日期 2003.10.08
申请号 AU20030233391 申请日期 2003.03.19
申请人 CYTYC HEALTH CORPORATION 发明人 DAVID HUNG
分类号 G01T1/161;A61K31/4545;A61K45/00;A61K51/00;A61K51/04;A61M31/00;A61P15/00;A61P35/00;A61P43/00;(IPC1-7):A61M31/00 主分类号 G01T1/161
代理机构 代理人
主权项
地址